Search clinical trials for: DBPR108; Placebo matching sitagliptin

Total 1364 results

Lotus Clinical Research, LLC
Novartis Pharmaceuticals

Completed

An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS

Pain | Delayed Onset Muscle Soreness

United States
Cerimon Pharmaceuticals
PPD

Terminated

Diclofenac Patch for Treatment of Mild to Moderate Ankle Sprain

Ankle Sprain

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT

Lung Neoplasm

United States
Vertex Pharmaceuticals Incorporated
ViroChem Pharma

Completed

Pharmacokinetics of Multiple Ascending Doses of VCH-222 in Subjects With Chronic Hepatitis C Infection

Hepatitis C

Canada, United States, Argentina, Puerto Rico
CHA University
Merck Sharp & Dohme LLC

Completed

Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.

Mild Persistent Asthma
Boehringer Ingelheim
Eli Lilly and Company

Completed

Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)

Diabetes Mellitus, Type 2

United States, Spain, Taiwan, United Kingdom, Czechia, Bulgaria, Israel, Canada, Germany, Malaysia, Argentina, Hungary, Russian Federation, Poland, Ukraine, Korea, Republic of, Croatia, Japan, Netherlands, Portugal, South Africa, ... and more
GlaxoSmithKline

Completed

A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults

Nausea and Vomiting, Chemotherapy-Induced

United States
BioDelivery Sciences International

Completed

Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film

Pain

United States
Boehringer Ingelheim
Eli Lilly and Company

Completed

Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug naïve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic Control

Diabetes Mellitus, Type 2

China, Malaysia, Philippines
Boehringer Ingelheim
Eli Lilly and Company

Completed

Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin Therapy

Diabetes Mellitus, Type 2

China, Malaysia, Philippines
Boehringer Ingelheim
Eli Lilly and Company

Completed

Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone

Diabetes Mellitus, Type 2

United States, France, India, Philippines
Boehringer Ingelheim
Eli Lilly and Company

Completed

Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Argentina, Belgium, Brazil, Canada, Czech Republic, Finland, Germany, Greece, Italy, Korea, Republic of, Mexico, Netherlands, Norway, Peru, Russian Federation, Slovakia, Spain, Taiwan
University Hospital, Basel, Switzerland

Completed

Tamoxifen in Duchenne Muscular Dystrophy (TAMDMD)

Duchenne Muscular Dystrophy

France, Spain, Germany, Netherlands, Switzerland, United Kingdom
Medical University of Vienna
AstraZeneca

Completed

Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus. (EXENDA)

Type2 Diabetes | Steatosis, Liver

Austria
Alcon Research

Completed

A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin

Glaucoma

United States
Cephalon

Completed

Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder

Excessive Sleepiness

United States
Menarini Group

Completed

Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic (no-cry)

Infantile Colic

Russian Federation, Germany, Poland, Sweden
Boehringer Ingelheim

Completed

Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms

Prostatic Hyperplasia
VA Office of Research and Development

Completed

Management of Cardiovascular Disease in Kidney Disease (MaCK) Study (MaCK)

Inflammation | Cardiovascular Disease | Atherosclerosis | Chronic Kidney Disease | Aortic Stiffness

United States
GlaxoSmithKline
PPD

Completed

Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

Hepatitis C, Chronic

Puerto Rico, United States
University of California, San Diego

Recruiting

Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease?

Obstructive Sleep Apnea | Alzheimer Disease | Sleep Apnea | OSA

United States
Mayo Clinic
University of Minnesota; Thorne Research Inc.

Completed

Use of 31P MRS to Assess Brain NAD+ in Healthy Current and Former Collegiate Athletes (TRMC-004)

Concussion, Mild

United States
Shire

Completed

SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder

Major Depressive Disorder

United States
University of Saskatchewan

Completed

Effect of Fluticasone Furoate on Methacholine Challenge

Asthma

Canada
Merck Sharp & Dohme LLC

Completed

Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)

Type 2 Diabetes Mellitus
GlaxoSmithKline

Terminated

A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.

Parkinson Disease

Japan
GlaxoSmithKline

Completed

Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic Patients

Asthma

United States
Novartis

Completed

Efficacy, Safety and Pharmacokinetics of QAV680 in Asthma Patients

Asthma

Germany, India
University of Pennsylvania
Lions Club International Foundation; Berhan Public Health and Eye Care Consultancy... and other collaborators

Completed

Fluorometholone as Ancillary Therapy for TT Surgery

Trachoma | Trichiasis | Bilamellar Tarsal Rotation

Ethiopia
Bausch & Lomb Incorporated

Completed

Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

Pain | Inflammation | Cataract

United States
University at Buffalo
Kaleida Health

Completed

The Effect of LINAGLIPTIN on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects (1971)

Type 2 Diabetes

United States
Duke University

Terminated

Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery (MAPSS)

Cardiovascular Disease | Type 2 Diabetes Mellitus

United States
Oslo University Hospital

Completed

Saxagliptin and Atherosclerosis (SAXATH)

Coronary Artery Disease | Diabetes Mellitus Type 2

Norway
AstraZeneca
Bristol-Myers Squibb

Completed

Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control

Type 2 Diabetes

Korea, Republic of, Philippines, China, India
BioXcel Therapeutics Inc
Cognitive Research Corporation

Completed

Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)

Dementia | Agitation

United States
BioXcel Therapeutics Inc
Cognitive Research Corporation

Terminated

Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)

Dementia | Agitation

United States
BioXcel Therapeutics Inc
Worldwide Clinical Trials

Active, not recruiting

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)

Schizophrenia | Schizoaffective Disorder | Bipolar I Disorder | Bipolar II Disorder | Agitation,Psychomotor | Schizophreniform Disorders

United States
Global Alliance for TB Drug Development

Completed

Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults

Tuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis Infection

United States
University of Erlangen-Nürnberg Medical School

Completed

Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes.

Type 2-diabetes

Germany
Boehringer Ingelheim
Eli Lilly and Company

Completed

Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study

Diabetes Mellitus, Type 2

United States
George Washington University
Boehringer Ingelheim

Completed

Linagliptin's Effect on CD34+ Stem Cells

Type 2 Diabetes | Impaired Renal Function

United States
Heart Care Foundation
Fondazione dell'Associazione Medici Diabetologi

Completed

Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry (DYDA2)

Diabetes Mellitus, Type 2 | Left Ventricular Systolic Dysfunction

Italy
George Washington University
AstraZeneca

Completed

Effect of Saxagliptin on EPCs as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early T2DM Patients

Type 2 Diabetes

United States
AstraZeneca
Bristol-Myers Squibb

Completed

Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications (SAVOR- TIMI 53)

Type 2 Diabetes Mellitus

Sweden, United States, Australia, Brazil, Czech Republic, Italy, Mexico, Peru, Poland, Russian Federation, South Africa, Spain, United Kingdom, Germany, China, Hungary, Netherlands, Canada, Hong Kong, Argentina, Chile, France, Israel, Puerto Rico and more
AstraZeneca
Bristol-Myers Squibb

Completed

Saxagliptin Triple Oral Therapy

Type 2 Diabetes

Korea, Republic of, United Kingdom, Australia, Canada, Thailand, India
AstraZeneca
Bristol-Myers Squibb

Completed

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Type 2 Diabetes

Croatia, United States, Bulgaria, Czech Republic, Poland, Russian Federation, Belarus, Estonia, Germany, Hungary, Latvia, Lithuania, Romania, Ukraine
Hoffmann-La Roche

Active, not recruiting

Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer (SKYSCRAPER-02C)

Small Cell Lung Carcinoma

China
Eli Lilly and Company
CoLucid Pharmaceuticals; SNBL Clinical Pharmacology Center, Inc.

Completed

Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants

Migraine

United States
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Completed

Modafinil Combined With Cognitive Behavior Therapy to Treat Cocaine Addiction - 1

Cocaine Dependence

United States
University of Miami
Novo Nordisk A/S

Recruiting

Liraglutide Effects on Epicardial Fat Inflammatory Genes

Coronary Artery Disease | Type2 Diabetes

United States

Search clinical trials for: DBPR108; Placebo matching sitagliptin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations